Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | L4EA4 | — |
A 1 month old male patient received a dose of Havrix.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-month-old male patient who received HAV (Havrix) (batch number L4EA4, expiry date 22-JAN-2027) for prophylaxis. On an unknown date, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced inappropriate age at vaccine administration (Verbatim: A 1 month old male patient received a dose of Havrix.). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-MAY-2025 The reporter reported that a pediatrician called to report the administration of Havrix to a 1 month old male patient, which led to inappropriate age at vaccine administration.